Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2006 1
2016 1
2019 4
2020 3
2021 7
2022 11
2023 14
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Towards Circulating-Tumor DNA-Based Precision Medicine.
Hironaka-Mitsuhashi A, Sanchez Calle A, Ochiya T, Takayama S, Suto A. Hironaka-Mitsuhashi A, et al. Among authors: suto a. J Clin Med. 2019 Sep 2;8(9):1365. doi: 10.3390/jcm8091365. J Clin Med. 2019. PMID: 31480647 Free PMC article. Review.
Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Sasada S, Kondo N, Hashimoto H, Takahashi Y, Terata K, Kida K, Sagara Y, Ueno T, Anan K, Suto A, Kanbayashi C, Takahashi M, Nakamura R, Ishiba T, Tsuneizumi M, Nishimura S, Naito Y, Hara F, Shien T, Iwata H. Sasada S, et al. Among authors: suto a. Breast Cancer Res Treat. 2023 Dec;202(3):473-483. doi: 10.1007/s10549-023-07097-6. Epub 2023 Sep 9. Breast Cancer Res Treat. 2023. PMID: 37688665 Free PMC article.
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.
Sanomachi T, Okuma HS, Kitadai R, Kawachi A, Yazaki S, Tokura M, Arakaki M, Saito A, Kita S, Yamamoto K, Maejima A, Kojima Y, Nishikawa T, Sudo K, Shimoi T, Noguchi E, Fujiwara Y, Sugino H, Shiino S, Suto A, Yoshida M, Yonemori K. Sanomachi T, et al. Among authors: suto a. Front Oncol. 2023 Mar 27;13:1157789. doi: 10.3389/fonc.2023.1157789. eCollection 2023. Front Oncol. 2023. PMID: 37051545 Free PMC article.
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer.
Miyakoshi J, Yazaki S, Shimoi T, Onishi M, Saito A, Kita S, Yamamoto K, Kojima Y, Sumiyoshi-Okuma H, Nishikawa T, Sudo K, Noguchi E, Murata T, Shiino S, Takayama S, Suto A, Fujiwara Y, Yoshida M, Yonemori K. Miyakoshi J, et al. Among authors: suto a. Virchows Arch. 2023 Dec;483(6):855-863. doi: 10.1007/s00428-023-03634-2. Epub 2023 Sep 5. Virchows Arch. 2023. PMID: 37668667
The Japanese Guidelines for Breast Cancer Screening.
Hamashima C; Japanese Research Group for the Development of Breast Cancer Screening Guidelines; Hamashima C C, Hattori M, Honjo S, Kasahara Y, Katayama T, Nakai M, Nakayama T, Morita T, Ohta K, Ohnuki K, Sagawa M, Saito H, Sasaki S, Shimada T, Sobue T, Suto A; Japanese Research Group for the Development of Breast Cancer Screening Guidelines. Hamashima C, et al. Among authors: suto a. Jpn J Clin Oncol. 2016 May;46(5):482-92. doi: 10.1093/jjco/hyw008. Epub 2016 Feb 18. Jpn J Clin Oncol. 2016. PMID: 27207993
37 results